pH-responsive and folate-coated liposomes encapsulating irinotecan as an alternative to improve efficacy of colorectal cancer treatment

Mechanistic insights into the intracellular release of doxorubicin from pH-sensitive liposomes

(2020) Samara Bonesso dos Reis et al.   BIOMEDICINE & PHARMACOTHERAPY

Paclitaxel-Loaded Folate-Coated pH-Sensitive Liposomes Enhance Cellular Uptake and Antitumor Activity

(2019) Liziane O. F. Monteiro et al.   MOLECULAR PHARMACEUTICS

Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model

(2019) Juliana de Oliveira Silva et al.   BIOMEDICINE & PHARMACOTHERAPY

pH‐Responsive PEG‐Shedding and Targeting Peptide‐Modified Nanoparticles for Dual‐Delivery of Irinotecan and microRNA to Enhance Tumor‐Specific Therapy

(2019) Vivian Juang et al.   Small

Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy

(2018) Zar Chi Soe et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Toxicological study of a new doxorubicin-loaded pH-sensitive liposome: A preclinical approach

(2018) Juliana de Oliveira Silva et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Metastatic and triple-negative breast cancer: challenges and treatment options

(2018) Sumayah Al-Mahmood et al.   Drug Delivery and Translational Research

A novel microfluidic liposomal formulation for the delivery of the SN-38 camptothecin: characterization and in vitro assessment of its cytotoxic effect on two tumor cell lines

(2018) Ana Casadó et al.   International Journal of Nanomedicine

Influence of PEG coating on the biodistribution and tumor accumulation of pH-sensitive liposomes

(2018) Shirleide Santos Nunes et al.   Drug Delivery and Translational Research

Investigation of the antitumor activity and toxicity of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in a murine breast cancer animal model

(2018) Marina Santiago Franco et al.   BIOMEDICINE & PHARMACOTHERAPY

Improved selectivity and cytotoxic effects of irinotecan via liposomal delivery: A comparative study on Hs68 and HeLa cells

(2017) Ana Casadó et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Evaluation of antitumor activity and cardiac toxicity of a bone-targeted ph-sensitive liposomal formulation in a bone metastasis tumor model in mice

(2017) Diego dos Santos Ferreira et al.   Nanomedicine-Nanotechnology Biology and Medicine

Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid

(2016) Shravan Kumar Sriraman et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

pH-Sensitive, Long-Circulating Liposomes as an Alternative Tool to Deliver Doxorubicin into Tumors: a Feasibility Animal Study

(2016) Juliana O. Silva et al.   MOLECULAR IMAGING AND BIOLOGY

Preliminary data of the antipancreatic tumor efficacy and toxicity of long-circulating and pH-sensitive liposomes containing cisplatin

(2016) Fernanda N. Carlesso et al.   NUCLEAR MEDICINE COMMUNICATIONS

Liposomal Drug Delivery: A Versatile Platform for Challenging Clinical Applications

(2016) Asadullah Madni et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

A Novel Folate-Targeted Nanoliposomal System of Doxorubicin for Cancer Targeting

(2015) Atul A. Lohade et al.   AAPS PHARMSCITECH

Bombesin Encapsulated in Long-Circulating pH-Sensitive Liposomes as a Radiotracer for Breast Tumor Identification

(2015) André Luís Branco de Barros et al.   Journal of Biomedical Nanotechnology

Systemic delivery of axitinib with nanohybrid liposomal nanoparticles inhibits hypoxic tumor growth

(2015) Ju Yeon Choi et al.   Journal of Materials Chemistry B

Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma

(2014) John C Castle et al.   BMC GENOMICS

State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines

(2014) Charlene M. Dawidczyk et al.   JOURNAL OF CONTROLLED RELEASE

Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems

(2013) John C. Kraft et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Treatment of Colorectal Cancer Using a Combination of Liposomal Irinotecan (Irinophore C™) and 5-Fluorouracil

(2013) Jennifer I. Hare et al.   PLoS One

Development of a Clinically-Precise Mouse Model of Rectal Cancer

(2013) Hiroyuki Kishimoto et al.   PLoS One

Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11)

(2013) S. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Active loading liposomal irinotecan hydrochloride: Preparation, in vitro and in vivo evaluation

(2013) Hongyan Wei et al.   Asian Journal of Pharmaceutical Sciences

Liposomal drug delivery systems: From concept to clinical applications

(2012) Theresa M. Allen et al.   ADVANCED DRUG DELIVERY REVIEWS

Tumor bombesin analog loaded long-circulating and pH-sensitive liposomes as tool for tumor identification

(2011) André Luís Branco de Barros et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Antitumoral activity and toxicity of PEG-coated and PEG-folate-coated pH-sensitive liposomes containing 159Gd-DTPA-BMA in Ehrlich tumor bearing mice

(2011) Daniel Crístian Ferreira Soares et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Targeted Gene Delivery Mediated by Folate-polyethylenimine-block-poly(ethylene glycol) with Receptor Selectivity

(2009) Han Cheng et al.   BIOCONJUGATE CHEMISTRY

A Novel Camptothecin Derivative Incorporated in Nano-Carrier Induced Distinguished Improvement in Solubility, Stability and Anti-tumor Activity Both In Vitro and In Vivo

(2008) Min Han et al.   PHARMACEUTICAL RESEARCH

Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro

(2008) K. Ghosh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA